Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Delavirdine mesylate

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (31)

10003

Beth Israel Med Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

21287

Johns Hopkins Hosp, Baltimore

27401

Moses H Cone Memorial Hosp, Greensboro

28203

Carolinas Med Ctr, Charlotte

29169

Julio Arroyo, West Columbia

35294

Univ of Alabama at Birmingham, Birmingham

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

60640

Louis A Weiss Memorial Hosp, Chicago

63112

St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis

80262

Univ of Colorado Health Sciences Ctr, Denver

94115

Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco

96816

Queens Med Ctr, Honolulu

Univ of Hawaii, Honolulu

212052196

State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore

275997215

Univ of North Carolina, Chapel Hill

331361013

Univ of Miami School of Medicine, Miami

432101228

Ohio State Univ Hosp Clinic, Columbus

441091998

MetroHealth Med Ctr, Cleveland

462025250

Indiana Univ Hosp, Indianapolis

921036325

Univ of California / San Diego Treatment Ctr, San Diego

943055107

San Mateo AIDS Program / Stanford Univ, Stanford

Stanford Univ Med Ctr, Stanford

951282699

Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose

981224304

Univ of Washington, Seattle

02215

Beth Israel Deaconess - West Campus, Boston

009365067

Univ of Puerto Rico, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH